Pa. Judge Narrows Class In Provigil Pay-For-Delay Suit
A Pennsylvania federal judge on Thursday narrowed the defined class of direct purchasers of Cephalon Inc.'s narcolepsy drug Provigil in a suit accusing Mylan Pharmaceuticals Inc. and Ranbaxy Pharmaceuticals Inc. of...To view the full article, register now.
Already a subscriber? Click here to view full article